Clinical characteristics and prognostic analysis of double primary breast cancer and thyroid cancer
10.3760/cma.j.cn112152-20210621-00461
- VernacularTitle:乳腺癌与甲状腺癌双原发的临床特征及预后
- Author:
Jie ZHAI
1
;
Xiangyi KONG
;
Yi FANG
;
Jing WANG
Author Information
1. 国家癌症中心 国家肿瘤临床医学研究中心 中国医学科学院北京协和医学院肿瘤医院乳腺外科 100021
- Keywords:
Breast neoplasms;
Thyroid neoplasms;
Double primary cancers;
Survival and prognosis;
Estrogen receptor
- From:
Chinese Journal of Oncology
2021;43(12):1287-1291
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore and describe clinicopathological characteristics and prognosis of patients with double primary breast cancer (BC) and thyroid cancer (TC).Methods:Medical records of 98 patients diagnosed with double primary breast and thyroid cancer in National Cancer Center (NCC)/Cancer Hospital between January 1, 2001 and December 31, 2020 were retrospectively collected. All of the patients were followed up until January 1, 2021 to acquire survival data. Univariate survival analysis was conducted by Kaplan-Meier method, and multivariate survival analysis was carried out using the Cox proportional hazard model.Results:All of 98 patients in the group were women. The age at diagnosis of the first tumor ranged from 26-72 years old, and the median age was 47 years old. The BC recurring TC (breast methyl) group included 18 cases, TC recurring BC (methyl breast) group included 60 cases, BC and TC simultaneously occurred group (the two are diagnosed within 3 months) included 20 cases. There were statistically significant differences in breast cancer pathological grading, breast cancer postoperative radiotherapy, and combined with other tumors in breast methyl group, methyl breast group and the simultaneous group ( P<0.05). Among the 98 patients, 14 had recurrence and metastasis, and 7 died. The patients who died from tumors were all those with TC recurrence of BC. There were no statistically significant differences in the death, recurrence and metastasis of patients in the breast methyl group, methyl breast group and the simultaneous group ( P>0.05). Univariate analysis showed that BC stage and estrogen receptor (ER) were related to overall survival ( P<0.05), while the family history of BC, BC stage, and ER were not related with the recurrence and metastasis ( P<0.05). Multivariate analysis showed that BC family history, ER positive, and the order of tumor diagnosis (TC recurring BC) were independent influencing factors for the recurrence and metastasis ( P<0.05). Conclusion:ER negative is a poor prognostic factor for the double primary breast and thyroid cancer.
